4 documents found, page 1 of 1
Stroke Etiology and Outcomes after Endovascular Thrombectomy: Results from the ...
Matusevicius, M; Cooray, C; Rand, VM; Nunes, AP; Moreira, T; Tassi, R; Egido, JA; Ollikainen, J; Bigliardi, G; Holmin, S; Ahmed, NBackground and purpose: The influence of stroke etiology on outcomes after endovascular thrombectomy (EVT) is not well understood. We aimed to investigate whether stroke etiology subgrouped as large artery atherosclerosis (LAA) and cardiac embolism (CE) influences outcomes in large artery occlusion (LAO) treated by EVT. Methods: We included EVT treated LAO stroke patients registered in the Safe Implementation o...
Magnitude of Blood Pressure Change and Clinical Outcomes after Thrombectomy in ...
Anadani, M; Matusevicius, M; Tsivgoulis, G; Peeters, A; Nunes, AP; Mancuso, M; Roffe, C; Havenon, A; Ahmed, NBackground: Extremes of both high and low systolic blood pressure (SBP) after mechanical thrombectomy (MT) in large artery occlusion stroke are known predictors of unfavorable outcome. However, the effect of SBP change (∆SBP) during the first 24 h on thrombectomy outcomes remains unclear. We aimed to investigate the association between ∆SBP at different time intervals and thrombectomy outcomes. Methods: We anal...
Dabigatran Initiation in Patients with Non-Valvular AF and First Acute Ischaemi...
Escudero-Martinez, I; Mazya, M; Teutsch, C; Lesko, N; Gdovinova, Z; Barbarini, L; Fryze, W; Karlinski, M; Kobayashi, A; Krastev, G; Paiva Nunes, ABackground and objective: The optimal timing for initiation of dabigatran after acute ischaemic stroke (AIS) is not established. We aimed to evaluate initiation timing and clinical outcomes of dabigatran in AIS patients with non-valvular atrial fibrillation (NVAF). Design: Retrospective study based on prospectively collected data in SITS (Safe Implementation of Treatment in Stroke) Thrombolysis and Thrombectomy...
Remote or Extraischemic Intracerebral Hemorrhage--an Uncommon Complication of S...
Mazya, M; Ahmed, N; Ford, G; Hobohm, C; Mikulik, R; Paiva Nunes, A; Wahlgren, NBackground and purpose: Intracerebral hemorrhage after treatment with intravenous recombinant tissue-type plasminogen activator for ischemic stroke can occur in local relation to the infarct, as well as in brain areas remote from infarcted tissue. We aimed to describe risk factors, 3-month mortality, and functional outcome in patients with the poorly understood complication of remote intracerebral hemorrhage, a...